# Amplifying Graft-Versus-Tumor Effect by Donor Regulatory T-Cell Depletion Before Donor Lymphocytes Infusion

> **NCT00987987** · PHASE1,PHASE2 · COMPLETED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 21 (actual)

## Conditions studied

- Hematologic Neoplasms
- Relapse

## Interventions

- **PROCEDURE:** donor lymphocyte infusion

## Key facts

- **NCT ID:** NCT00987987
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-12
- **Primary completion:** 2009-12
- **Final completion:** 2009-12
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2011-01-24

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00987987

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00987987, "Amplifying Graft-Versus-Tumor Effect by Donor Regulatory T-Cell Depletion Before Donor Lymphocytes Infusion". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00987987. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*